Guidance

Vaccination against pertussis (whooping cough) for pregnant women

This vaccination programme helps protect infants from whooping cough by boosting pertussis immunity in pregnant women.

Documents

Vaccination against pertussis (whooping cough) for pregnant women: information for healthcare professionals

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (eg a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Vaccination against pertussis (whooping cough) for pregnant women: an update for healthcare professionals

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (eg a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail

The vaccination programme is recommended for pregnant women from 16 weeks to 32 weeks of pregnancy, although the vaccine can be offered up to 38 weeks. It is usually offered after the fetal anomaly scan. Vaccinating pregnant women between 16 to 32 weeks of pregnancy will ensure that high levels of antibodies against pertussis cross the placenta from the mother to passively protect the baby when it is born.

Further programme information: